Zions Bancorporation N.A. trimmed its position in The Allstate Co. (NYSE:ALL – Free Report) by 8.3% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 918 shares of the insurance provider’s stock after selling 83 shares during the period. Zions Bancorporation N.A.’s holdings in Allstate were worth $174,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. SPC Financial Inc. increased its position in Allstate by 3.6% in the third quarter. SPC Financial Inc. now owns 1,564 shares of the insurance provider’s stock worth $297,000 after purchasing an additional 54 shares during the period. Lake Street Advisors Group LLC raised its stake in shares of Allstate by 1.8% during the third quarter. Lake Street Advisors Group LLC now owns 3,129 shares of the insurance provider’s stock worth $596,000 after buying an additional 54 shares during the last quarter. Abacus Planning Group Inc. lifted its holdings in Allstate by 2.4% in the third quarter. Abacus Planning Group Inc. now owns 2,416 shares of the insurance provider’s stock valued at $458,000 after buying an additional 56 shares during the period. Chicago Partners Investment Group LLC boosted its stake in Allstate by 1.3% in the third quarter. Chicago Partners Investment Group LLC now owns 4,630 shares of the insurance provider’s stock valued at $893,000 after acquiring an additional 59 shares during the last quarter. Finally, Carmichael Hill & Associates Inc. grew its holdings in Allstate by 15.0% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 460 shares of the insurance provider’s stock worth $87,000 after acquiring an additional 60 shares during the period. 76.47% of the stock is owned by institutional investors and hedge funds.
Allstate Trading Up 0.6 %
NYSE ALL opened at $196.88 on Friday. The stock has a market capitalization of $52.13 billion, a price-to-earnings ratio of 12.75, a PEG ratio of 1.75 and a beta of 0.48. The Allstate Co. has a 52 week low of $131.65 and a 52 week high of $201.00. The stock’s 50 day moving average price is $189.79 and its two-hundred day moving average price is $176.53. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40.
Allstate Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, November 29th will be issued a dividend of $0.92 per share. The ex-dividend date of this dividend is Friday, November 29th. This represents a $3.68 annualized dividend and a yield of 1.87%. Allstate’s payout ratio is presently 23.83%.
Analyst Ratings Changes
ALL has been the topic of several recent research reports. Raymond James raised their price target on Allstate from $205.00 to $220.00 and gave the stock a “strong-buy” rating in a research report on Friday, October 4th. UBS Group boosted their target price on Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. Wells Fargo & Company increased their price target on shares of Allstate from $175.00 to $186.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 5th. TD Cowen boosted their price objective on shares of Allstate from $193.00 to $224.00 and gave the company a “buy” rating in a report on Tuesday, September 3rd. Finally, StockNews.com lowered shares of Allstate from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 21st. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Allstate presently has a consensus rating of “Moderate Buy” and an average target price of $214.19.
View Our Latest Stock Report on Allstate
Insider Buying and Selling
In related news, insider John E. Dugenske sold 36,367 shares of the firm’s stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This trade represents a 57.06 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Toohey sold 16,682 shares of the business’s stock in a transaction on Monday, August 19th. The stock was sold at an average price of $180.17, for a total transaction of $3,005,595.94. Following the transaction, the executive vice president now owns 4,873 shares in the company, valued at approximately $877,968.41. The trade was a 77.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 143,049 shares of company stock worth $26,106,112. Corporate insiders own 1.80% of the company’s stock.
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories
- Five stocks we like better than Allstate
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- What is the Shanghai Stock Exchange Composite Index?
- Top-Performing Non-Leveraged ETFs This Year
- Election Stocks: How Elections Affect the Stock Market
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.